$51.57 0.66 (+1.30%)
12/4/2009 10:20 AM

SPDR S&P Biotech (ETF) (XBI)

CAPS Rating: 4 out of 5

Exchange traded funds

Current Price $51.57 Mkt Cap $412.56M
Open $51.30 P/E Ratio 0.00
Prev. Close $50.91 Div. (Yield) 0.60 (1.20%)
Daily Range $51.30 - $51.89 Volume 57,716
52-Wk Range $43.06 - $56.92 Avg. Daily Vol. 195,000

XBI News and Commentary

Related News and Articles

Caps

How do you think XBI will perform vs the S&P 500?

Add Stock to Watchlist

All Members

98 Outperform
5 Underperform
 

All-Star Members

33 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top XBI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.57)
Submitted March 02, 2009

Is this the right time to call a bottom in the latest biotech plunge? It's hard to know, but I am the kind of guy that enjoys a nice bottom. So here goes ...

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

XBI VS S&P 500 (SPY)

Fools bullish on XBI are also bullish on:

Fools bearish on XBI are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about XBI.

Recs

0
Member Avatar notsoitsybitsy (39.56) Submitted: 10/12/2009 3:17:25 PM : Outperform Start Price: $50.89 XBI Score: -2.69

Great basket of biotechnology stocks. Long-term health-care play.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar darksabre (33.55) Submitted: 7/29/2009 11:57:37 AM : Outperform Start Price: $55.13 XBI Score: -22.07

Healthcare

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar LoneWolf888 (< 20) Submitted: 7/25/2009 5:09:06 PM : Outperform Start Price: $54.77 XBI Score: -20.79

Biotechs will be the hottest performing sector driven by two factors:
1) Obama's healthcare debacle will drive Big Pharma into the less profitable generics market. Looking for more profitable streams of revenue, Big P will buy biotch firms as a means to increase potential top line revenues.
2) Baby boomers are geometrically increasing. Hence, the "silver bullit" search for AD and MS drugs as well as Oncology drugs will continue unabated.

Report this Post 0 Comments | Reply | Permalink
View All 20 Pitches »

Leaderboard

Find the members with the highest scoring picks in XBI.

Score Leader

elgin74

elgin74 (98.55) Score: +34.95

The Score Leader is the member with the highest score across all their picks in XBI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
dgalbraith100 80.04 1/17/2007 Outperform 5Y $48.13 +7.14% -16.81% +23.95
gdigrandi < 20 1/18/2007 Outperform 1Y $48.28 +6.81% -16.99% +23.80
ffedericoni 72.41 1/17/2007 Outperform 3M $48.40 +6.55% -17.04% +23.60
redsox189 82.31 7/20/2007 Outperform 5Y $51.46 +0.21% -23.35% +23.55 1 Comment
AndyChip38 < 20 7/6/2007 Outperform NS $51.19 +0.75% -22.65% +23.40
DRewids 40.58 2/13/2007 Outperform NS $48.75 +5.78% -17.34% +23.11
Restlesspegger 87.44 2/22/2007 Outperform 5Y $49.32 +4.55% -18.43% +22.98
CantFindAUsernam < 20 11/5/2008 Underperform 1Y $55.21 -6.59% +15.77% +22.36
ETFs 86.73 12/11/2006 Outperform 5Y $48.67 +5.95% -15.97% +21.91
AggieInIraq 32.04 11/13/2006 Outperform NS $49.81 +3.54% -13.99% +17.53
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for XBI.

Featured Broker Partners